CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Medeze Group PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Medeze Group PLC
NAKHON PATHOM, 73220  Thailand Ticker: MEDEZEMEDEZE

Business Summary
Medeze Group Plc is a Thailand-based company operating as a mesenchymal stem cell bank. It offers stem cell storage services from umbilical cord tissue and adipose tissue, in addition to the storage of umbilical cord blood. It is engaged in providing stem cell analysis, separation, cultivation and storage services and provide immune cell potential testing services with biotechnology. Its stem cell sample collection service segment provides collection and storage services, sorting, cultivation and development of stem cells. Its white blood cell potential testing service segment offers potential testing services that evaluate the performance and count the number of Natural killer cells (NK cells). Its other services segment provides other services, such as research services, develop and collect data on all types of human cellular activities and medical laboratory test. Its sales of products segment provide sales of dietary supplements, cosmetics, and dermo cosmetics.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023-----

General Information
Outstanding Shares: 1,068,000,000 (As of 10/15/2024)
Stock Exchange: BAK
Fax Number: +66 24822995


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024